Table 1 Patient characteristics

Age (years)

61.5 ± 13.7

63.5 ± 11.5

0.7813

Men

5 (62.5 %)

3 (50.0 %)

0.1477

Body surface area (m²)

1.64 ± 0.11

1.60 ± 0.10

0.5998

NYHA class III or IV (n, %)

4 (50 %)

1 (16.7 %)

0.1977

 Hb (g/dL)

10.9 ± 1.8

10.4 ± 1.1

0.5397

 Na (mEq/L)

139.1 ± 4.0

136.0 ± 3.6

0.1567

 Cre (mg/dL)

1.20 ± 0.54

1.02 ± 0.28

0.478

 T-Bil (mg/dL)

1.4 ± 0.6

1.02 ± 0.2

0.408

 TP (g/dL)

6.2 ± 0.5

6.3 ± 0.2

0.792

 Alb (g/dL)

3.5 ± 0.3

3.5 ± 0.2

0.831

 eGFR (ml/min./1.73 m²)

47.6 ± 26.6

52.9 ± 14.4

0.668

 CKD stage 3b or worse (n, %)

4 (50 %)

2 (33.3 %)

0.533

 LVEDD (mm)

56.8 ± 19.8

50.3 ± 9.4

0.371

 LVEF (%)

43.1 ± 14.0

52.0 ± 6.7

0.180

 TAPSE (mm)

16.0 ± 5.0

20.3 ± 3.1

0.086

 RVFAC (%)

33.5 ± 7.1

38.3 ± 6.5

0.214

Euroscore

12.6 ± 8.1

8.0 ± 4.0

0.2486

Japan Score

15.9 ± 11.8

10.1 ± 5.1

0.2820

Type of surgery (p value based on CABG alone vs. others)

0.0499

 CABG alone

0 (0 %)

2 (33.3 %)

 Valvular surgery alone

5 (62.5 %)

3 (50.0 %)

 CABG + Valvular surgery

1 (12.5 %)

1 (16.7 %)

 Pericardiectomy

1 (12.5 %)

0 (16.7 %)

 Pulmonary thrombectomy

1 (12.5 %)

0 (16.7 %)